Study of microalbuminuria in essential hypertension patients with target organ damage

Vijay Bakhtar, Niyati Bakhtar, Kirit Pandey, Neha Pandey


Background: Urinary albumin excretion has been purported to be strongly linked to cardiovascular events in hypertensive patients. The prevalence of microalbuminuria in patients with essential hypertension and its relationship with target organ damage was evaluated with the present study, as the correlation of microalbuminuria and target organ damage except cardiovascular events has not been deliberated upon much in the past.

Methods: One hundred and twenty cases of essential hypertension were enrolled sequentially. Prevalence of urinary albumin excretion and its correlation with target organ damage (left ventricular hypertrophy, retinopathy and stroke) was analyzed. Urinary albumin excretion was assessed by turbidimetry method, while microalbuminuria was calculated by urine albumin to creatinine ratio.

Results: Microalbuminuria was observed in 57.7% cases of essential hypertension. Target organ damage was observed in 62.5% (75) patients, out of which 78.66% patients had associated microalbuminuria (p<0.05). Higher prevalence was observed in patients with longer duration and greater severity of hypertension, increased body mass index and dyslipidemia.

Conclusions: The assessment of microalbuminuria in hypertensive patients is a great value addition for the evaluation of target organ damage. Prompt control of hypertension and lipid levels along with weight management may lead to decreased risk of microalbuminuria.


Essential hypertension, Microalbuminuria, Target organ damage, Urinary albumin

Full Text:



Pickering GW. The natural history of hypertension. Bri Med Bull. 1952 Jan 1;8(4):305-9.

Anchala R, Kannuri NK, Pant H, Khan H, Franco OH, Di Angelantonio E, et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hyper. 2014 Jun;32(6):1170.

Reddy KS, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet. 2005 Nov 12;366(9498):1744-9.

Tagle R, Acevedo M, Vidt DG. Microalbuminuria: is it a valid predictor of cardiovascular risk. Cleve Clin J Med. 2003 Mar 1;70(3):255-61.

Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron. 1992;61(1):94-7.

Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hyper. 1996 Feb;14(2):223-8.

Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population: the EPIC-Norfolk study. Am J Epidemiol. 2004 Feb 1;159(3):284-93.

Cheng AY. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: Canadian diabetes association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabe. 2013 Apr;37(1):S1-212.

Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999 May 1;33(5):1004-10.

American Diabetes Association. Diabetic nephropathy. Diabe Care 2001;24(1): S69-72.

Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. New Eng J Med. 2006 Jun 8;354(23):2473-83.

Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC study. Hypertension. 1997 Nov;30(5):1135-43.

Hitha B, Pappachan JM, Pillai HB, Sujathan P, Ramakrishna CD, Jayaprakash K, et al. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience. Saudi J Kidney Dis Trans. 2008 May 1;19(3):411.

Leoncini G, Sacchi G, Ravera M, Viazzi F, Ratto E, Vettoretti S, et al. Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. J Human Hyper. 2002 Jun;16(6):399.

Plavnik FL, Silva MA, Kohlmann NE, Kohlmann Jr O, Ribeiro AB, Zanella MT. Relationship between microalbuminuria and cardiac structural changes in mild hypertensive patients. Braz J Med Bio Res. 2002 Jul;35(7):799-804.

Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. New Eng J Med. 1984 Feb 9;310(6):356-60.

Deckert T, Kofoed-Enevoldsen A, Nørgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria: implications for micro-and macrovascular disease. Diabe Care. 1992 Sep 1;15(9):1181-91.

Palatini P, Graniero GR, Canali C, Santonastaso M, Mos L, Piccolo D, et al. Relationship between albumin excretion rate, ambulatory blood pressure and left ventricular hypertrophy in mild hypertension. J Hyper. 1995 Dec;13(12 Pt 2):1796-800.

Hebert LA, Spetie DN, Keane WF. The urgent call of albuminuria/proteinuria: heeding its significance in early detection of kidney disease. Postgrad Med. 2001 Oct 1;110(4):79-96.

Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Archiv Int Med. 1998 Sep 28;158(17):1933-9.

Palatini P. Microalbuminuria in hypertension. Current Hypertension Reports. 2003 Jun;5(3):208-14.